YANELLE OLMOS: Open Payments
NPI 1609546928 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,978 in 76 payments from 13 companies in 2025. Trend: 2023 $4,265 · 2024 $3,272 · 2025 $1,978
Food & beverage: $1,965Education: $13
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $432 |
| Amgen Inc. | 10 | $309 |
| PFIZER INC. | 11 | $281 |
| AstraZeneca Pharmaceuticals LP | 3 | $240 |
| Novo Nordisk Inc | 16 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $181 |
| Lilly USA, LLC | 7 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| ViiV Healthcare Company | 1 | $28 |
Products named: OTEZLA, VRAYLAR, BREZTRI, JARDIANCE, QULIPTA, ZAVZPRET, Rybelsus, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
